Studies of Molecular Mechanisms Underlying Cardioprotective Action of the ALM-802 Compound

The mechanisms underlying cardioprotective activity of compound ALM-802 were studied in experiments on rats with chronic post-infarction heart failure. Real-time PCR showed that compound ALM-802 (daily intraperitoneal injections in a dose of 2 mg/kg for 28 days starting from day 91 after myocardial infarction modeling) restored the expression of genes encoding β1- ( p =0.00001) and β2-adrenoreceptors ( p =0.01) and type 2 ryanodine receptors ( p =0.008) in the myocardium that was reduced in control animals. These effects can serve as the basis for the ability of the compound to reduce the intensity of remodeling and increase the inotropic function of the left heart ventricle shown earlier in this model.

[1]  C. Maack,et al.  Metabolic remodelling in heart failure , 2018, Nature Reviews Cardiology.

[2]  B. Hill,et al.  Metabolic Coordination of Physiological and Pathological Cardiac Remodeling , 2018, Circulation research.

[3]  C. Lang,et al.  Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure , 2017, Diseases.

[4]  I. Efimov,et al.  Arrhythmogenic and metabolic remodelling of failing human heart , 2016, The Journal of physiology.

[5]  P. Ponikowski,et al.  Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure. , 2016, International journal of cardiology.

[6]  Andrew D. McCulloch,et al.  Calcium and IP3 dynamics in cardiac myocytes: experimental and computational perspectives and approaches , 2014, Front. Pharmacol..

[7]  K. Fukunaga,et al.  Diverse regulation of IP3 and ryanodine receptors by pentazocine through σ1-receptor in cardiomyocytes. , 2013, American journal of physiology. Heart and circulatory physiology.

[8]  I. Komuro,et al.  Ryanodine Receptor Type 2 Is Required for the Development of Pressure Overload-Induced Cardiac Hypertrophy , 2011, Hypertension.

[9]  K. Mikoshiba,et al.  The IP3 Receptor Regulates Cardiac Hypertrophy in Response to Select Stimuli , 2010, Circulation research.

[10]  F. Lezoualc’h,et al.  The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytes , 2007, The Journal of physiology.

[11]  Huan Wang,et al.  Epac-mediated Activation of Phospholipase Cϵ Plays a Critical Role in β-Adrenergic Receptor-dependent Enhancement of Ca2+ Mobilization in Cardiac Myocytes* , 2007, Journal of Biological Chemistry.

[12]  Ali Ahmed,et al.  Myocardial beta‐1 adrenoceptor down‐regulation in aging and heart failure: implications for beta‐blocker use in older adults with heart failure , 2003, European journal of heart failure.